These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 17009911)

  • 1. Psychosis in Parkinson's disease: how should we treat it?
    Shotbolt P; Samuel M; Anthony D
    Expert Rev Neurother; 2006 Sep; 6(9):1243-6. PubMed ID: 17009911
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of the behavioral aspects of Parkinson's disease.
    Borek LL; Chou KL; Friedman JH
    Expert Rev Neurother; 2007 Jun; 7(6):711-25. PubMed ID: 17563253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intervening in the neuropsychiatric features of Parkinson's disease.
    Weintraub D; Stern MB
    Expert Rev Neurother; 2007 Jun; 7(6):699-710. PubMed ID: 17563252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parenteral ziprasidone: a new atypical neuroleptic for emergency treatment of psychosis in Parkinson's disease?
    Oechsner M; Korchounov A
    Hum Psychopharmacol; 2005 Apr; 20(3):203-5. PubMed ID: 15799011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychosis in nursing home patients with Parkinson's disease.
    Kang GA; Bronstein JM
    J Am Med Dir Assoc; 2004; 5(3):167-73. PubMed ID: 15115577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychosis in Parkinson's disease.
    Wint DP; Okun MS; Fernandez HH
    J Geriatr Psychiatry Neurol; 2004 Sep; 17(3):127-36. PubMed ID: 15312276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Session 3 "Analyzer Workshop" evolution of therapeutic strategies in Parkinson's disease.
    Yanagisawa N; Yamamoto M; Kikuchi S; Murata M; Ohkuma Y
    J Neurol; 2004 Oct; 251 Suppl 7():vII24-30. PubMed ID: 15505751
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of psychotic symptoms associated with the disease and its treatments.
    Monias A; Samuels SC
    Geriatrics; 2001 Nov; 56(11):56-7. PubMed ID: 11710816
    [No Abstract]   [Full Text] [Related]  

  • 9. When a Parkinson's disease patient starts to hallucinate.
    Poewe W
    Pract Neurol; 2008 Aug; 8(4):238-41. PubMed ID: 18644910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychosis in Parkinson's disease: case studies.
    Salter BC; Anderson KE; Weiner WJ
    Neurol Clin; 2006 May; 24(2):363-9. PubMed ID: 16684637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychosis in Parkinson's disease.
    Poewe W
    Mov Disord; 2003 Sep; 18 Suppl 6():S80-7. PubMed ID: 14502660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugs to treat dementia and psychosis: management of Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S120-7. PubMed ID: 12211152
    [No Abstract]   [Full Text] [Related]  

  • 13. Clozapine: new preparation. A last resort for parkinsonian patients with psychosis.
    Prescrire Int; 2002 Feb; 11(57):1-6. PubMed ID: 11985366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clozapine for drug-induced psychosis in Parkinson's disease.
    Brown TM
    N Engl J Med; 1999 Aug; 341(6):456. PubMed ID: 10438274
    [No Abstract]   [Full Text] [Related]  

  • 15. Antipsychotic treatment of UHR ('prodromal') individuals.
    Yung AR
    Early Interv Psychiatry; 2010 Aug; 4(3):197-9. PubMed ID: 20712723
    [No Abstract]   [Full Text] [Related]  

  • 16. [Psychosis in Parkinson's disease].
    Rongve A; Auning E; Ehrt U; Arsland D
    Tidsskr Nor Laegeforen; 2012 Jan; 132(2):155-8. PubMed ID: 22278271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease.
    Meco G; Bernardi S
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):311-3. PubMed ID: 16919377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pimavanserin for Parkinson Disease Psychosis.
    Mohanty D; Sarai S; Naik S; Lippmann S
    Prim Care Companion CNS Disord; 2019 Apr; 21(2):. PubMed ID: 31050230
    [No Abstract]   [Full Text] [Related]  

  • 19. Mirtazapine improves visual hallucinations in Parkinson's disease: a case report.
    Tagai K; Nagata T; Shinagawa S; Tsuno N; Ozone M; Nakayama K
    Psychogeriatrics; 2013 Jun; 13(2):103-7. PubMed ID: 23909968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pimavanserin (Nuplazid) for Parkinson's disease psychosis.
    Med Lett Drugs Ther; 2016 Jun; 58(1496):74-5. PubMed ID: 27249096
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.